世界のエリスロポエチン（EPO）薬剤市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Erythropoietin (EPO) Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4206 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、エリスロポエチン（EPO）薬剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エポエチンアルファ、ダルベポエチンアルファ）、用途別市場規模（病院、ホームケア、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・エリスロポエチン（EPO）薬剤の市場動向 ・企業の競争状況、市場シェア ・エリスロポエチン（EPO）薬剤の種類別市場規模と予測2016-2027（エポエチンアルファ、ダルベポエチンアルファ） ・エリスロポエチン（EPO）薬剤の用途別市場規模と予測2016-2027（病院、ホームケア、専門クリニック、その他） ・エリスロポエチン（EPO）薬剤の北米市場規模2016-2027（アメリカ、カナダ） ・エリスロポエチン（EPO）薬剤の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・エリスロポエチン（EPO）薬剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・エリスロポエチン（EPO）薬剤の中南米市場規模2016-2027（メキシコ、ブラジル） ・エリスロポエチン（EPO）薬剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Roche、Amgen、Johnson & Johnson、Kyowa Kirin、Shanghai Dahua Pharmaceutical、JCR Pharmaceuticals、Teva Pharmaceuticals） ・結論

It is a glycoprotein hormone that controls the production of red blood cells, or the production of red blood cells.

Market Analysis and Insights: Global Erythropoietin (EPO) Drugs Market
The global Erythropoietin (EPO) Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Erythropoietin (EPO) Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Erythropoietin (EPO) Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Erythropoietin (EPO) Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Erythropoietin (EPO) Drugs market.

Global Erythropoietin (EPO) Drugs Scope and Market Size
Erythropoietin (EPO) Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Erythropoietin (EPO) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Epoetin-alfa
Darbepoetin-alfa

Segment by Application
Hospitals
Homecare
Specialty Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Roche
Amgen
Johnson & Johnson
Kyowa Kirin
Shanghai Dahua Pharmaceutical
JCR Pharmaceuticals
Teva Pharmaceuticals

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Erythropoietin (EPO) Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Epoetin-alfa
1.2.3 Darbepoetin-alfa
1.3 Market by Application
1.3.1 Global Erythropoietin (EPO) Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Erythropoietin (EPO) Drugs Market Perspective (2016-2027)
2.2 Erythropoietin (EPO) Drugs Growth Trends by Regions
2.2.1 Erythropoietin (EPO) Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Erythropoietin (EPO) Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Erythropoietin (EPO) Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Erythropoietin (EPO) Drugs Industry Dynamic
2.3.1 Erythropoietin (EPO) Drugs Market Trends
2.3.2 Erythropoietin (EPO) Drugs Market Drivers
2.3.3 Erythropoietin (EPO) Drugs Market Challenges
2.3.4 Erythropoietin (EPO) Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Erythropoietin (EPO) Drugs Players by Revenue
3.1.1 Global Top Erythropoietin (EPO) Drugs Players by Revenue (2016-2021)
3.1.2 Global Erythropoietin (EPO) Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Erythropoietin (EPO) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Erythropoietin (EPO) Drugs Revenue
3.4 Global Erythropoietin (EPO) Drugs Market Concentration Ratio
3.4.1 Global Erythropoietin (EPO) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Erythropoietin (EPO) Drugs Revenue in 2020
3.5 Erythropoietin (EPO) Drugs Key Players Head office and Area Served
3.6 Key Players Erythropoietin (EPO) Drugs Product Solution and Service
3.7 Date of Enter into Erythropoietin (EPO) Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Erythropoietin (EPO) Drugs Breakdown Data by Type
4.1 Global Erythropoietin (EPO) Drugs Historic Market Size by Type (2016-2021)
4.2 Global Erythropoietin (EPO) Drugs Forecasted Market Size by Type (2022-2027)

5 Erythropoietin (EPO) Drugs Breakdown Data by Application
5.1 Global Erythropoietin (EPO) Drugs Historic Market Size by Application (2016-2021)
5.2 Global Erythropoietin (EPO) Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Erythropoietin (EPO) Drugs Market Size (2016-2027)
6.2 North America Erythropoietin (EPO) Drugs Market Size by Type
6.2.1 North America Erythropoietin (EPO) Drugs Market Size by Type (2016-2021)
6.2.2 North America Erythropoietin (EPO) Drugs Market Size by Type (2022-2027)
6.2.3 North America Erythropoietin (EPO) Drugs Market Size by Type (2016-2027)
6.3 North America Erythropoietin (EPO) Drugs Market Size by Application
6.3.1 North America Erythropoietin (EPO) Drugs Market Size by Application (2016-2021)
6.3.2 North America Erythropoietin (EPO) Drugs Market Size by Application (2022-2027)
6.3.3 North America Erythropoietin (EPO) Drugs Market Size by Application (2016-2027)
6.4 North America Erythropoietin (EPO) Drugs Market Size by Country
6.4.1 North America Erythropoietin (EPO) Drugs Market Size by Country (2016-2021)
6.4.2 North America Erythropoietin (EPO) Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Erythropoietin (EPO) Drugs Market Size (2016-2027)
7.2 Europe Erythropoietin (EPO) Drugs Market Size by Type
7.2.1 Europe Erythropoietin (EPO) Drugs Market Size by Type (2016-2021)
7.2.2 Europe Erythropoietin (EPO) Drugs Market Size by Type (2022-2027)
7.2.3 Europe Erythropoietin (EPO) Drugs Market Size by Type (2016-2027)
7.3 Europe Erythropoietin (EPO) Drugs Market Size by Application
7.3.1 Europe Erythropoietin (EPO) Drugs Market Size by Application (2016-2021)
7.3.2 Europe Erythropoietin (EPO) Drugs Market Size by Application (2022-2027)
7.3.3 Europe Erythropoietin (EPO) Drugs Market Size by Application (2016-2027)
7.4 Europe Erythropoietin (EPO) Drugs Market Size by Country
7.4.1 Europe Erythropoietin (EPO) Drugs Market Size by Country (2016-2021)
7.4.2 Europe Erythropoietin (EPO) Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Erythropoietin (EPO) Drugs Market Size (2016-2027)
8.2 Asia-Pacific Erythropoietin (EPO) Drugs Market Size by Type
8.2.1 Asia-Pacific Erythropoietin (EPO) Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Erythropoietin (EPO) Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Erythropoietin (EPO) Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Erythropoietin (EPO) Drugs Market Size by Application
8.3.1 Asia-Pacific Erythropoietin (EPO) Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Erythropoietin (EPO) Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Erythropoietin (EPO) Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Erythropoietin (EPO) Drugs Market Size by Region
8.4.1 Asia-Pacific Erythropoietin (EPO) Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Erythropoietin (EPO) Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Erythropoietin (EPO) Drugs Market Size (2016-2027)
9.2 Latin America Erythropoietin (EPO) Drugs Market Size by Type
9.2.1 Latin America Erythropoietin (EPO) Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Erythropoietin (EPO) Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Erythropoietin (EPO) Drugs Market Size by Type (2016-2027)
9.3 Latin America Erythropoietin (EPO) Drugs Market Size by Application
9.3.1 Latin America Erythropoietin (EPO) Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Erythropoietin (EPO) Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Erythropoietin (EPO) Drugs Market Size by Application (2016-2027)
9.4 Latin America Erythropoietin (EPO) Drugs Market Size by Country
9.4.1 Latin America Erythropoietin (EPO) Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Erythropoietin (EPO) Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Erythropoietin (EPO) Drugs Market Size (2016-2027)
10.2 Middle East & Africa Erythropoietin (EPO) Drugs Market Size by Type
10.2.1 Middle East & Africa Erythropoietin (EPO) Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Erythropoietin (EPO) Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Erythropoietin (EPO) Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Erythropoietin (EPO) Drugs Market Size by Application
10.3.1 Middle East & Africa Erythropoietin (EPO) Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Erythropoietin (EPO) Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Erythropoietin (EPO) Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Erythropoietin (EPO) Drugs Market Size by Country
10.4.1 Middle East & Africa Erythropoietin (EPO) Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Erythropoietin (EPO) Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Erythropoietin (EPO) Drugs Introduction
11.1.4 Pfizer Revenue in Erythropoietin (EPO) Drugs Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Erythropoietin (EPO) Drugs Introduction
11.2.4 Roche Revenue in Erythropoietin (EPO) Drugs Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Erythropoietin (EPO) Drugs Introduction
11.3.4 Amgen Revenue in Erythropoietin (EPO) Drugs Business (2016-2021)
11.3.5 Amgen Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Erythropoietin (EPO) Drugs Introduction
11.4.4 Johnson & Johnson Revenue in Erythropoietin (EPO) Drugs Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Kyowa Kirin
11.5.1 Kyowa Kirin Company Details
11.5.2 Kyowa Kirin Business Overview
11.5.3 Kyowa Kirin Erythropoietin (EPO) Drugs Introduction
11.5.4 Kyowa Kirin Revenue in Erythropoietin (EPO) Drugs Business (2016-2021)
11.5.5 Kyowa Kirin Recent Development
11.6 Shanghai Dahua Pharmaceutical
11.6.1 Shanghai Dahua Pharmaceutical Company Details
11.6.2 Shanghai Dahua Pharmaceutical Business Overview
11.6.3 Shanghai Dahua Pharmaceutical Erythropoietin (EPO) Drugs Introduction
11.6.4 Shanghai Dahua Pharmaceutical Revenue in Erythropoietin (EPO) Drugs Business (2016-2021)
11.6.5 Shanghai Dahua Pharmaceutical Recent Development
11.7 JCR Pharmaceuticals
11.7.1 JCR Pharmaceuticals Company Details
11.7.2 JCR Pharmaceuticals Business Overview
11.7.3 JCR Pharmaceuticals Erythropoietin (EPO) Drugs Introduction
11.7.4 JCR Pharmaceuticals Revenue in Erythropoietin (EPO) Drugs Business (2016-2021)
11.7.5 JCR Pharmaceuticals Recent Development
11.8 Teva Pharmaceuticals
11.8.1 Teva Pharmaceuticals Company Details
11.8.2 Teva Pharmaceuticals Business Overview
11.8.3 Teva Pharmaceuticals Erythropoietin (EPO) Drugs Introduction
11.8.4 Teva Pharmaceuticals Revenue in Erythropoietin (EPO) Drugs Business (2016-2021)
11.8.5 Teva Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Erythropoietin (EPO) Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Epoetin-alfa
Table 3. Key Players of Darbepoetin-alfa
Table 4. Global Erythropoietin (EPO) Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Erythropoietin (EPO) Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Erythropoietin (EPO) Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Erythropoietin (EPO) Drugs Market Share by Regions (2016-2021)
Table 8. Global Erythropoietin (EPO) Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Erythropoietin (EPO) Drugs Market Share by Regions (2022-2027)
Table 10. Erythropoietin (EPO) Drugs Market Trends
Table 11. Erythropoietin (EPO) Drugs Market Drivers
Table 12. Erythropoietin (EPO) Drugs Market Challenges
Table 13. Erythropoietin (EPO) Drugs Market Restraints
Table 14. Global Erythropoietin (EPO) Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Erythropoietin (EPO) Drugs Market Share by Players (2016-2021)
Table 16. Global Top Erythropoietin (EPO) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erythropoietin (EPO) Drugs as of 2020)
Table 17. Ranking of Global Top Erythropoietin (EPO) Drugs Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Erythropoietin (EPO) Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Erythropoietin (EPO) Drugs Product Solution and Service
Table 21. Date of Enter into Erythropoietin (EPO) Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Erythropoietin (EPO) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Erythropoietin (EPO) Drugs Revenue Market Share by Type (2016-2021)
Table 25. Global Erythropoietin (EPO) Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Erythropoietin (EPO) Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Erythropoietin (EPO) Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Erythropoietin (EPO) Drugs Revenue Market Share by Application (2016-2021)
Table 29. Global Erythropoietin (EPO) Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Erythropoietin (EPO) Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Erythropoietin (EPO) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Erythropoietin (EPO) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Erythropoietin (EPO) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Erythropoietin (EPO) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Erythropoietin (EPO) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Erythropoietin (EPO) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Erythropoietin (EPO) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Erythropoietin (EPO) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Erythropoietin (EPO) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Erythropoietin (EPO) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Erythropoietin (EPO) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Erythropoietin (EPO) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Erythropoietin (EPO) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Erythropoietin (EPO) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Erythropoietin (EPO) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Erythropoietin (EPO) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Erythropoietin (EPO) Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Erythropoietin (EPO) Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Erythropoietin (EPO) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Erythropoietin (EPO) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Erythropoietin (EPO) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Erythropoietin (EPO) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Erythropoietin (EPO) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Erythropoietin (EPO) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Erythropoietin (EPO) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Erythropoietin (EPO) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Erythropoietin (EPO) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Erythropoietin (EPO) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Erythropoietin (EPO) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Erythropoietin (EPO) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Erythropoietin (EPO) Drugs Product
Table 64. Pfizer Revenue in Erythropoietin (EPO) Drugs Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Roche Company Details
Table 67. Roche Business Overview
Table 68. Roche Erythropoietin (EPO) Drugs Product
Table 69. Roche Revenue in Erythropoietin (EPO) Drugs Business (2016-2021) & (US$ Million)
Table 70. Roche Recent Development
Table 71. Amgen Company Details
Table 72. Amgen Business Overview
Table 73. Amgen Erythropoietin (EPO) Drugs Product
Table 74. Amgen Revenue in Erythropoietin (EPO) Drugs Business (2016-2021) & (US$ Million)
Table 75. Amgen Recent Development
Table 76. Johnson & Johnson Company Details
Table 77. Johnson & Johnson Business Overview
Table 78. Johnson & Johnson Erythropoietin (EPO) Drugs Product
Table 79. Johnson & Johnson Revenue in Erythropoietin (EPO) Drugs Business (2016-2021) & (US$ Million)
Table 80. Johnson & Johnson Recent Development
Table 81. Kyowa Kirin Company Details
Table 82. Kyowa Kirin Business Overview
Table 83. Kyowa Kirin Erythropoietin (EPO) Drugs Product
Table 84. Kyowa Kirin Revenue in Erythropoietin (EPO) Drugs Business (2016-2021) & (US$ Million)
Table 85. Kyowa Kirin Recent Development
Table 86. Shanghai Dahua Pharmaceutical Company Details
Table 87. Shanghai Dahua Pharmaceutical Business Overview
Table 88. Shanghai Dahua Pharmaceutical Erythropoietin (EPO) Drugs Product
Table 89. Shanghai Dahua Pharmaceutical Revenue in Erythropoietin (EPO) Drugs Business (2016-2021) & (US$ Million)
Table 90. Shanghai Dahua Pharmaceutical Recent Development
Table 91. JCR Pharmaceuticals Company Details
Table 92. JCR Pharmaceuticals Business Overview
Table 93. JCR Pharmaceuticals Erythropoietin (EPO) Drugs Product
Table 94. JCR Pharmaceuticals Revenue in Erythropoietin (EPO) Drugs Business (2016-2021) & (US$ Million)
Table 95. JCR Pharmaceuticals Recent Development
Table 96. Teva Pharmaceuticals Company Details
Table 97. Teva Pharmaceuticals Business Overview
Table 98. Teva Pharmaceuticals Revenue in Erythropoietin (EPO) Drugs Business (2016-2021) & (US$ Million)
Table 99. Teva Pharmaceuticals Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Erythropoietin (EPO) Drugs Market Share by Type: 2020 VS 2027
Figure 2. Epoetin-alfa Features
Figure 3. Darbepoetin-alfa Features
Figure 4. Global Erythropoietin (EPO) Drugs Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Homecare Case Studies
Figure 7. Specialty Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Erythropoietin (EPO) Drugs Report Years Considered
Figure 10. Global Erythropoietin (EPO) Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Erythropoietin (EPO) Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Erythropoietin (EPO) Drugs Market Share by Regions: 2020 VS 2027
Figure 13. Global Erythropoietin (EPO) Drugs Market Share by Regions (2022-2027)
Figure 14. Global Erythropoietin (EPO) Drugs Market Share by Players in 2020
Figure 15. Global Top Erythropoietin (EPO) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erythropoietin (EPO) Drugs as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Erythropoietin (EPO) Drugs Revenue in 2020
Figure 17. Global Erythropoietin (EPO) Drugs Revenue Market Share by Type (2016-2021)
Figure 18. Global Erythropoietin (EPO) Drugs Revenue Market Share by Type (2022-2027)
Figure 19. North America Erythropoietin (EPO) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Erythropoietin (EPO) Drugs Market Share by Type (2016-2027)
Figure 21. North America Erythropoietin (EPO) Drugs Market Share by Application (2016-2027)
Figure 22. North America Erythropoietin (EPO) Drugs Market Share by Country (2016-2027)
Figure 23. United States Erythropoietin (EPO) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Erythropoietin (EPO) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Erythropoietin (EPO) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Erythropoietin (EPO) Drugs Market Share by Type (2016-2027)
Figure 27. Europe Erythropoietin (EPO) Drugs Market Share by Application (2016-2027)
Figure 28. Europe Erythropoietin (EPO) Drugs Market Share by Country (2016-2027)
Figure 29. Germany Erythropoietin (EPO) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Erythropoietin (EPO) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Erythropoietin (EPO) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Erythropoietin (EPO) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Erythropoietin (EPO) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Erythropoietin (EPO) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Erythropoietin (EPO) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Erythropoietin (EPO) Drugs Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Erythropoietin (EPO) Drugs Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Erythropoietin (EPO) Drugs Market Share by Region (2016-2027)
Figure 39. China Erythropoietin (EPO) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Erythropoietin (EPO) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Erythropoietin (EPO) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Erythropoietin (EPO) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Erythropoietin (EPO) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Erythropoietin (EPO) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Erythropoietin (EPO) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Erythropoietin (EPO) Drugs Market Share by Type (2016-2027)
Figure 47. Latin America Erythropoietin (EPO) Drugs Market Share by Application (2016-2027)
Figure 48. Latin America Erythropoietin (EPO) Drugs Market Share by Country (2016-2027)
Figure 49. Mexico Erythropoietin (EPO) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Erythropoietin (EPO) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Erythropoietin (EPO) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Erythropoietin (EPO) Drugs Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Erythropoietin (EPO) Drugs Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Erythropoietin (EPO) Drugs Market Share by Country (2016-2027)
Figure 55. Turkey Erythropoietin (EPO) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Erythropoietin (EPO) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Erythropoietin (EPO) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Erythropoietin (EPO) Drugs Business (2016-2021)
Figure 59. Roche Revenue Growth Rate in Erythropoietin (EPO) Drugs Business (2016-2021)
Figure 60. Amgen Revenue Growth Rate in Erythropoietin (EPO) Drugs Business (2016-2021)
Figure 61. Johnson & Johnson Revenue Growth Rate in Erythropoietin (EPO) Drugs Business (2016-2021)
Figure 62. Kyowa Kirin Revenue Growth Rate in Erythropoietin (EPO) Drugs Business (2016-2021)
Figure 63. Shanghai Dahua Pharmaceutical Revenue Growth Rate in Erythropoietin (EPO) Drugs Business (2016-2021)
Figure 64. JCR Pharmaceuticals Revenue Growth Rate in Erythropoietin (EPO) Drugs Business (2016-2021)
Figure 65. Teva Pharmaceuticals Revenue Growth Rate in Erythropoietin (EPO) Drugs Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---